Press Releases on December 4, 2018 - EIN Presswire - Press Release Distribution Service

Published on December 4, 2018 - 02:15 GMT

Poseida Therapeutics Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Product Candidate at the 2018 American Society of ...

SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, today provided an update on the ongoing …

Distribution channels: Technology ...

Published on December 4, 2018 - 02:15 GMT

Updated Interim Results from Ongoing Phase 2a Study of Portola Pharmaceuticals’ Oral Syk/JAK Inhibitor Cerdulatinib Continues to ...

– Early Signs of Durable Response Across Patients with Relapsed/Refractory PTCL – – 50 Percent Complete Response Rate Observed in Patients with AITL – – Rapid and Significant Reduction in Itching Among Patients with CTCL – SOUTH SAN FRANCISCO, Calif., …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2018 - 02:03 GMT

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Tesaro, Inc. (TSRO) on Behalf of Stockholders and ...

NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Tesaro, Inc. (NASDAQ: TSRO) on behalf of stockholders concerning the proposed acquisition of the company by …

Distribution channels: Consumer Goods, Law ...

Published on December 4, 2018 - 02:00 GMT

Mitel Partners with Tradewinds Brokerage to Accelerate UCaaS Business in Australia, New Zealand

Enhances regional alignment with Mitel’s global go-to-market approach and strategic focus on accelerating the move to cloud Allows technology resellers to confidently transition customers to UCaaS with the support and experience of the Mitel and Tradewinds …

Distribution channels: Banking, Finance & Investment Industry, Telecommunications ...

Published on December 4, 2018 - 01:52 GMT

Nutrigenomix opens new office in London and expands genetic testing service for personalized nutrition across Europe

TORONTO, ON, CANADA, December 3, 2018 /⁨EINPresswire.com⁩/ -- Nutrigenomix Inc., a global leader in genetic testing for personalized nutrition, announces the opening of their first European office in the UK. The office is situated near Tech City in East …

Distribution channels: Food & Beverage Industry, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2018 - 01:48 GMT

Kayne Anderson Midstream/Energy Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset ...

HOUSTON, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Kayne Anderson Midstream/Energy Fund, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the …

Distribution channels: Banking, Finance & Investment Industry

Published on December 4, 2018 - 01:48 GMT

Kayne Anderson MLP/Midstream Investment Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and ...

HOUSTON, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Kayne Anderson MLP/Midstream Investment Company (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under …

Distribution channels: Banking, Finance & Investment Industry

Published on December 4, 2018 - 01:45 GMT

Atara Biotherapeutics Announces Next-Generation CAR T Discoveries and Positive T-Cell Immunotherapy Results in Patients with EBV+ ...

Moffitt Cancer Center collaborators described next-generation chimeric antigen receptor T-cell (CAR T) technology that increases T cell persistence and decreases exhaustion Memorial Sloan Kettering collaborators presented positive Phase 2 clinical results …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2018 - 01:13 GMT

Bragar Eagel & Squire, P.C. is Investigating Aphria Inc. (APHA) on Behalf of Stockholders and Encourages APHA Investors to Contact ...

NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Aphria Inc. (NYSE: APHA). Our investigation concerns whether Aphria has violated the federal securities laws and/or engaged in other …

Distribution channels: Consumer Goods, Law ...

Published on December 4, 2018 - 00:45 GMT

Allogene Therapeutics and Servier Present Pooled Data from Phase 1 Trials of Allogeneic UCART19 in Relapsed/Refractory Acute ...

82 percent of Patients Achieved a Complete Remission when Lymphodepletion Regimen Included an anti-CD52 Monoclonal Antibody (mAb) Safety Profile of UCART19 Appears Manageable with No Evidence of Moderate or Severe Graft-vs-Host Disease (GvHD) and No Severe …

Distribution channels: Healthcare & Pharmaceuticals Industry ...